Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 26 - 34 of 34 in total
GSK690693 has been used in trials studying the treatment of Tumor, CANCER, and Lymphoma.
Investigational
Matched Name: … GSK-690693 …
GSK-364735 (Naphthyridinone) has been used in trials studying the treatment of HIV-1 Infection and Infection, Human Immunodeficiency Virus.
Investigational
Matched Name: … GSK-364735 …
Matched Description: … GSK-364735 (Naphthyridinone) has been used in trials studying the treatment of HIV-1 Infection and Infection …
GSK-239512 is under investigation in clinical trial NCT00474513 (An Imaging Study to Investigate the Distribution of GSK239512 in the Brain.).
Investigational
Matched Name: … GSK-239512 …
Matched Description: … GSK-239512 is under investigation in clinical trial NCT00474513 (An Imaging Study to Investigate the …
GSK-269962A is a Rho kinase (ROCK) inhibitor with both ROCK1 and ROCK2 affinity.
Investigational
Matched Name: … GSK-269962A …
Matched Description: … GSK-269962A is a Rho kinase (ROCK) inhibitor with both ROCK1 and ROCK2 affinity.[A253012] …
GSK1059615 has been used in trials studying the treatment of Lymphoma, Solid Tumours, Endometrial Cancer, Solid Tumor Cancer, and Metastatic Breast Cancer.
Investigational
Matched Name: … GSK-1059615 …
GSK2018682 has been investigated for the treatment of Multiple Sclerosis, Relapsing-Remitting.
Investigational
Matched Name: … GSK-2018682 …
Gsk1004723 has been investigated for the treatment of Allergic Rhinitis and Rhinitis, Allergic, Seasonal.
Investigational
Matched Name: … GSK-1004723 …
Investigational
Matched Name: … GSK-2881078 …
Investigational
Matched Synonyms: … GSK-2696275 …
Displaying drugs 26 - 34 of 34 in total